Renalase deficiency in heart failure model of rats-A potential mechanism underlying circulating norepinephrine accumulation

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Gu, Rong ^a   Lu, Wen ^a   Xie, Jun ^a   Bai, Jian ^a   Xu, Biao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CATECHOLAMINE; NORADRENALIN; RENALASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME SYNTHESIS; HEART FAILURE; HEART FUNCTION; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; NONHUMAN; NORADRENALIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RENALASE DEFICIENCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BLOOD; DISEASE MODEL; ENZYMOLOGY; KIDNEY; KIDNEY CIRCULATION; METABOLISM; VASCULARIZATION;

RATTUS;

ANIMALS; DISEASE MODELS, ANIMAL; HEART FAILURE; KIDNEY; MONOAMINE OXIDASE; NOREPINEPHRINE; RATS; RENAL CIRCULATION;

EID: 79551621412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014633     Document Type: Article

References (23)

1. Kaye DM, Krum H (2007) Drug discovery for heart failure: a new era or the end of the pipeline? Nat Rev Drug Discov 6: 127-139.
2. Negrao CE, Middlekauff HR (2008) Adaptations in autonomic function during exercise training in heart failure. Heart Fail Rev 13: 51-60.
3. Mircoli L, Fedele L, Benetti M, Bolla GB, Radaelli A, et al. (2002) Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure. Circulation 106: 866-872.
4. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, et al. (1995) Adverse Consequences of High Sympathetic Nervous Activity in the Failing Human Heart. J Am Coll Cardiol 26: 1257-1263.
5. Liang CS (2007) Cardiac sympathetic nerve terminal function in congestive heart failure. Acta Pharmacol Sin 28(7): 921-927.
6. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, et al. (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621.
7. Xu J, Li G, Wang P, Velazquez H, Yao X, et al. (2005) Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115: 1275-1280.
8. Li G, Xu J, Wang P, Velazquez H, Li Y, et al. (2008) Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 117: 1277-1282.
9. Russo LM, McKee M, Brown D (2006) Methyl-b-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 291: 246-253.
10. Taft DR (2004) The isolated perfused rat kidney model: a useful tool for drug discovery and development. Current Drug Discovery Technologies 1: 97-111.
11. Zhang J, Ding L, Zhao Y, Sun W, Chen B, et al. (2009) Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction. Circulation 119: 1776-1784.
12. Communal C, Singh K, Pimentel DR, Colucci WS (1998) Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the ßadrenergic pathway. Circulation 98: 1329-1334.
13. Mann DL, Kent RL, Parsons B, IV GC (1992) Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85: 790-804.
14. Meredith IT, Broughton A, Jennings GL, Esler MD (1991) Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325: 618-624.
15. Dibner-Dunlap ME, Thames MD (1989) Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ Res 65: 1526-1535.
16. DiBona GF, Sawin LL (1995) Increased renal nerve activity in cardiac failure: Arterial vs. cardiac baroreflex impairment. Am J Physiol 268: R112-R116.
17. Dibona GF, Jones SY, Brooks VL (1995) ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol 269: R1189-1196.
18. Gao L, Wang W, Li YL, Schultz HD, Liu D, et al. (2004) Superoxide mediates sympathoexcitation in heart failure: Roles of angiotensin II and NAD(P)H oxidase. Circ Res 95: 937-944.
19. Zucker IH, Schultz HD, Li YF, Wang Y, Wang W, et al. (2004) The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol 84: 217-232.
20. Reid IA (1992) Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 262: E763-E778.
21. Zhao Q, Fan Z, He J, Chen S, Li H, et al. (2007) Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med 85: 877-885.
22. Ghosh SS, Krieg RJ, Sica DA, Wang R, Fakhry I, et al. (2009) Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system. Pediatr Nephrol 24(2): 367-377.
23. Magri P, Rao MAE, Cangianiello S, Bellizzi V, Russo R, et al. (1998) Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation 98: 2849-2854.